Page last updated: 2024-12-08

3-bromotyrosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-bromotyrosine: RN refers to DL-Tyr isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID148708
CHEBI ID80911
SCHEMBL ID455224
MeSH IDM0303315

Synonyms (24)

Synonym
3-bromotyrosine
2-amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid
C17079
3-bromo-tyrosine
54788-30-6
FT-0696130
dl-tyrosine, 3-bromo-
3-bromo-dl-tyrosine
AKOS016009174
2-amino-3-(3-bromo-4-hydroxy-phenyl)propanoic acid
FT-0689945
SCHEMBL455224
CHEBI:80911
2-amino-3-(3-bromo-4-hydroxyphenyl)propanoicacid
Q27151411
2-amino-3-(3-bromo-4-hydroxyphenyl);propanoic acid
mfcd09842061
2-amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid (h-dl-tyr(3-br)-oh)
AS-44315
DTXSID30970126
SY108324
CS-0157103
EN300-297318
PD078083
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's10 (45.45)29.6817
2010's8 (36.36)24.3611
2020's3 (13.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.00 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.35%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]